Cigna Corporation (CI)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for CI is $335.33, 10.9% above the last close of $302.30 on Oct 16, 2026; targets range from $290.21 to $401.40. Rating consensus: Buy.
Snapshot
- P/E12.5x
- P/E vs sector-55.6%
- P/E vs own+4.6%
- Target upside+10.9%
- ConsensusBuy
- Market cap$79.88B
- FCF yield+11.4%
- Insiders-$6.29M
- Earnings in20d
- News0.00
Why it moved
Cigna Corporation (CI) rose 1.2% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.8%. Most of the move is specific to CI.
0 stories on the day (30-day average 0.7).
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $302.30 · +6.2% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendbearish
- Sector▲ +16.0%
- MAs20▲ 50▲ 100▲ 200▲
- Above MAs4 of 4 above
- MA20×50↑ in ~4d
- RSI73
- Support-2.6%
- Resistance+0.7%
- Off 52w high-0.2%
- Off ATH-14.1%
- 52w range$302.30
- Bollingerabove upper
- MACD3.18
- ATR+2.5%
- Volume0.9x
Analyst price targets
16 firms with a target in the last 12 months · last close $302.30 · as of Oct 16, 2026
Strong buy 6 · Buy 12 · Hold 6 · Sell 0 · Strong sell 0
Revenue and free cash flow
Q2 FY2026: Revenue +6.6% year over year, free cash flow -1.0% of revenue, operating margin 3.7%.
| Q2 FY2026 | Jun 30, 2026 | $71.67B | 6.29 | -$718M | 20.9% | 3.7% | 2.3% |
| Q1 FY2026 | Mar 31, 2026 | $68.49B | 6.26 | $864M | 9.4% | 3.4% | 2.4% |
| Q4 FY2025 | Dec 31, 2025 | $72.47B | 4.64 | $5.83B | 7.7% | 3.0% | 1.7% |
| Q3 FY2025 | Sep 30, 2025 | $69.75B | 6.97 | $3.14B | 8.5% | 3.7% | 2.7% |
| Q2 FY2025 | Jun 30, 2025 | $67.23B | 5.71 | -$2.17B | 11.7% | 3.6% | 2.3% |
| Q1 FY2025 | Mar 31, 2025 | $65.5B | 4.85 | $1.59B | 10.1% | 3.0% | 2.0% |
| Q4 FY2024 | Dec 31, 2024 | $65.65B | 5.13 | $4.88B | 9.8% | 3.3% | 2.2% |
| Q3 FY2024 | Sep 30, 2024 | $63.69B | 2.63 | -$353M | 10.4% | 4.0% | 1.2% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $401.43 | -1.3% | -7.4% | +14.6% | 22.9 | $360B | |
| 2 |  | $92.36 | -0.2% | -16.0% | +20.9% | 24.4 | $118B | |
| 3 |  | $428.26 | 0.0% | 0.0% | +1.9% | 19.0 | $92.88B | |
| 4 |  | $218.01 | -7.8% | -7.8% | -25.0% | — | $87.04B | |
| 5 |  | $790.74 | -0.7% | -7.2% | +8.7% | 19.6 | $81.41B | |
| 6 | | $302.30 | +1.2% | -0.2% | +10.9% | 12.5 | $79.88B | |
| 7 |  | $413.16 | -4.4% | -4.7% | +15.7% | 39.1 | $49.63B | |
| 8 |  | $69.16 | -1.9% | -1.9% | -0.5% | — | $34.16B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.